151 research outputs found
Coupling of ATPase activity, microtubule binding, and mechanics in the dynein motor domain.
The movement of a molecular motor protein along a cytoskeletal track requires communication between enzymatic, polymer-binding, and mechanical elements. Such communication is particularly complex and not well understood in the dynein motor, an ATPase that is comprised of a ring of six AAA domains, a large mechanical element (linker) spanning over the ring, and a microtubule-binding domain (MTBD) that is separated from the AAA ring by a ~ 135 Å coiled-coil stalk. We identified mutations in the stalk that disrupt directional motion, have microtubule-independent hyperactive ATPase activity, and nucleotide-independent low affinity for microtubules. Cryo-electron microscopy structures of a mutant that uncouples ATPase activity from directional movement reveal that nucleotide-dependent conformational changes occur normally in one-half of the AAA ring, but are disrupted in the other half. The large-scale linker conformational change observed in the wild-type protein is also inhibited, revealing that this conformational change is not required for ATP hydrolysis. These results demonstrate an essential role of the stalk in regulating motor activity and coupling conformational changes across the two halves of the AAA ring
Self-supervised learning in non-small cell lung cancer discovers novel morphological clusters linked to patient outcome and molecular phenotypes
Histopathological images provide the definitive source of cancer diagnosis,
containing information used by pathologists to identify and subclassify
malignant disease, and to guide therapeutic choices. These images contain vast
amounts of information, much of which is currently unavailable to human
interpretation. Supervised deep learning approaches have been powerful for
classification tasks, but they are inherently limited by the cost and quality
of annotations. Therefore, we developed Histomorphological Phenotype Learning,
an unsupervised methodology, which requires no annotations and operates via the
self-discovery of discriminatory image features in small image tiles. Tiles are
grouped into morphologically similar clusters which appear to represent
recurrent modes of tumor growth emerging under natural selection. These
clusters have distinct features which can be identified using orthogonal
methods. Applied to lung cancer tissues, we show that they align closely with
patient outcomes, with histopathologically recognised tumor types and growth
patterns, and with transcriptomic measures of immunophenotype
Actes de la Journée des innovations pour une alimentation durable - JIPAD 2020
La Journée des Innovations pour une Alimentation Durable édition 2020 a eu lieu cette année exceptionnellement en streaming interactif et en direct, le lundi 12 octobre de 13h à 17h. Les trois thématiques abordées ont été : Paysages alimentaires : les comprendre, les habiter, pouvoir les construire ; La terre, l'eau, la biodiversité : les enjeux prioritaires pour réunir citoyens et collectivités autour de la transition alimentaire ; Des leviers pour plus de durabilité au sein des filières alimentaires
Actes de la Journée des innovations pour une alimentation durable - JIPAD 2021
La Journée des Innovations pour une Alimentation Durable édition 2021 a eu lieu le jeudi 1er avril 2021 en partenariat avec Le Monde Nouveau / Midi Libre. Retrouvez les vidéos des innovations des étudiant·es du Mastère IPAD et les tables rondes animées par un journaliste de Midi Libre. Cinq thématiques ont été abordées : Outils de relocalisation ; Gouvernance ; Valorisation des productions ; Éducation – Sensibilisation ; Démocratie alimentaire
Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer
Self-supervised learning (SSL) automates the extraction and interpretation of histopathology features on unannotated hematoxylin-and-eosin-stained whole-slide images (WSIs). We trained an SSL Barlow Twins-encoder on 435 TCGA colon adenocarcinoma WSIs to extract features from small image patches. Leiden community detection then grouped tiles into histomorphological phenotype clusters (HPCs). HPC reproducibility and predictive ability for overall survival was confirmed in an independent clinical trial cohort (N=1213 WSIs). This unbiased atlas resulted in 47 HPCs displaying unique and sharing clinically significant histomorphological traits, highlighting tissue type, quantity, and architecture, especially in the context of tumor stroma. Through in-depth analysis of these HPCs, including immune landscape and gene set enrichment analysis, and association to clinical outcomes, we shed light on the factors influencing survival and responses to treatments like standard adjuvant chemotherapy and experimental therapies. Further exploration of HPCs may unveil new insights and aid decision-making and personalized treatments for colon cancer patients
Inflammation in the Tumor-Adjacent Lung as a Predictor of Clinical Outcome in Lung Adenocarcinoma
Approximately 30% of early-stage lung adenocarcinoma patients present with disease progression after successful surgical resection. Despite efforts of mapping the genetic landscape, there has been limited success in discovering predictive biomarkers of disease outcomes. Here we performed a systematic multi-omic assessment of 143 tumors and matched tumor-adjacent, histologically-normal lung tissue with long-term patient follow-up. Through histologic, mutational, and transcriptomic profiling of tumor and adjacent-normal tissue, we identified an inflammatory gene signature in tumor-adjacent tissue as the strongest clinical predictor of disease progression. Single-cell transcriptomic analysis demonstrated the progression-associated inflammatory signature was expressed in both immune and non-immune cells, and cell type-specific profiling in monocytes further improved outcome predictions. Additional analyses of tumor-adjacent transcriptomic data from The Cancer Genome Atlas validated the association of the inflammatory signature with worse outcomes across cancers. Collectively, our study suggests that molecular profiling of tumor-adjacent tissue can identify patients at high risk for disease progression
Artificial Intelligence algorithm predicts response to immune checkpoint inhibitors
Purpose: Cancer treatment has been revolutionized by the immune checkpoint inhibitors (ICIs). However, a subset of patients do not respond and/or experience significant adverse events. Attempts to integrate reliable biomarkers of ICI response as part of standard care have been hampered by limited generalizability. We previously reported our supervised machine learning (ML) model in a retrospective cohort of metastatic melanoma. Experimental Design: Here, we expanded our testing to include larger cohorts of melanoma patients accrued at several sites, including patients enrolled in clinical trials in both adjuvant and metastatic settings. We examined pre-treatment hematoxylin and eosin slides from 639 patients with stage III/IV melanoma treated with ICI (anti-CTLA-4 n=212, anti-PD-1 n=271, or the combination n=156). We tested the generalizability of our supervised ML algorithm to predict response to ICI in the metastatic melanoma cohort, then developed a self-supervised ML model to identify the histologic morphologies associated with patients' survival following ICI use in adjuvant and metastatic melanoma cohorts. Results: We predicted the response to ICI with an area under the curve of 0.72. The deep convolutional neural network classified patients into high and low risk based on their likelihood of progression-free survival (P < 0.0001). We uncovered a novel association of specific histomorphological tumor features - epithelioid histology and a low tumor-stroma ratio - with survival following ICI treatment. Conclusions: Our data support the generalizability of our developed ML algorithm in predicting response to ICI in patients with metastatic unresectable melanoma. We also showed, for the first time, tumor features associated with patients' overall survival
Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides
Cancer diagnosis and management depend upon the extraction of complex information from microscopy images by pathologists, which requires time-consuming expert interpretation prone to human bias. Supervised deep learning approaches have proven powerful, but are inherently limited by the cost and quality of annotations used for training. Therefore, we present Histomorphological Phenotype Learning, a self-supervised methodology requiring no labels and operating via the automatic discovery of discriminatory features in image tiles. Tiles are grouped into morphologically similar clusters which constitute an atlas of histomorphological phenotypes (HP-Atlas), revealing trajectories from benign to malignant tissue via inflammatory and reactive phenotypes. These clusters have distinct features which can be identified using orthogonal methods, linking histologic, molecular and clinical phenotypes. Applied to lung cancer, we show that they align closely with patient survival, with histopathologically recognised tumor types and growth patterns, and with transcriptomic measures of immunophenotype. These properties are maintained in a multi-cancer study
Self Supervised Artificial Intelligence Predicts Poor Outcome From Primary Cutaneous Squamous Cell Carcinoma at Diagnosis
Primary cutaneous squamous cell carcinoma (cSCC) is responsible for ~10,000 deaths annually in the United States. Stratification of risk of poor outcome at initial biopsy would significantly impact clinical decision-making during the initial post operative period where intervention has been shown to be most effective. Using whole-slide images (WSI) from 163 patients from 3 institutions, we developed a self supervised deep-learning model to predict poor outcomes in cSCC patients from histopathological features at initial diagnosis, and validated it using WSI from 563 patients, collected from two other academic institutions. For disease-free survival prediction, the model attained a concordance index of 0.73 in the development cohort and 0.84 in the Mayo cohort. The model\u27s interpretability revealed that features like poor differentiation and deep invasion were strongly associated with poor prognosis. Furthermore, the model is effective in stratifying risk among BWH T2a and AJCC T2, known for outcome heterogeneity
- …
